Ronald Levy, MD

Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.

Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. Int Rev Immunol. 1989; 4 (4): 251-70

PubMedID: 2519929